§ Mr. BellottiTo ask the Secretary of State for Health, pursuant to the reply of 14 February,Official Report, columns 553–54, if he will list the reasons why the Bio Products Laboratory, as a special health authority, is not being made fully accountable for its income and expenditure; and whether these will be reported.
§ Mr. DorrellThe Bio Products Laboratory (BPL) is the manufacturing arm of the Central Blood Laboratory Authority (CBLA). The CBLA is a special health authority which does account for the performance of all parts of the organisation and produces an annual report.